Trials / Completed
CompletedNCT01830426
Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
Phase 2 Study of Circulating Tumor Cell in Non-Small Cell Lung Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 232 (actual)
- Sponsor
- Epic Sciences · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to establish the circulating tumor cell (CTC) assay as a surrogate for tissue diagnosis of suspected primary lung cancer. This is done through evaluating clinical and molecular markers to stratify the outcome/survival in patients with thoracic malignancies treated at Yale University/Yale-New Haven Hospital, University of California San Diego/Moores Cancer Center, Billings Clinic Cancer Center.
Conditions
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-12-01
- Completion
- 2016-01-01
- First posted
- 2013-04-12
- Last updated
- 2016-01-22
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01830426. Inclusion in this directory is not an endorsement.